Dr. Corey William Waldman, MD

Dr. Waldman practices at Sabates Eye Centers in Kansas City, Missouri.

Dr. Waldman's NPI, 1871851832, was assigned on April 27, 2012. Dr. Waldman graduated from UMKC School of Medicine in 2012. Dr. Waldman's Kansas license number on file is 04-49877.

Dr. Waldman's primary practice is Sabates Eye Centers, at 5811 NW Barry Rd, Kansas City, MO 64154 in Platte County. The practice phone is (913) 261-2020.

Dr. Waldman's primary practice is Sabates Eye Centers in Kansas City, Missouri. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Waldman to 2 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waldman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Waldman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Waldman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Waldman's licenses on file in 5 states: Kansas, Maryland, Missouri, Texas and Massachusetts.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Waldman treats.

CMS data shows 1,093 Medicare services from Dr. Waldman across 16 procedure codes in 2024, for 343 Medicare patients. Medicare paid $96,640 for them.

CMS counts 343 Medicare patients who saw Dr. Waldman in 2024. The largest group is 75 to 84, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Waldman's median patient age at 69, with 58% women.

In 2024, Dr. Waldman wrote 2,220 Medicare Part D claims for 427 patients. 61% of them were for generic drugs. CMS names the drug for 2,135 of them, across 23 drugs with 11 or more claims each, at $365,072 in total drug cost. In 2023, CMS named 2,888 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Waldman for performance year 2024, reported through an alternative payment model (APM). Dr. Waldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 166 procedures of cataract surgery by Dr. Waldman, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Waldman, published from 2012 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Eye Diseases and Eye Pain. Dr. Waldman has published most often in Clin Dermatol. Dr. Waldman's most frequent co-authors are Lorin Alyssa Bibb, MD, Effie Zhu Rahman, MD and Steven Brett Sloan, MD.

CMS Open Payments shows 41 general payments to Dr. Waldman from 13 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Glaukos Corporation paid the most, $2,680.

Dr. Waldman graduated from UMKC School of Medicine in 2012.

Dr. Waldman is in network with 19 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.